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Camp dogs in indigenous communities in the Western Australian Kimberley Region, share the domestic 
environment with humans and have the potential to act as carriers of, and sentinels for, a wide range 
of zoonotic agents, including intestinal parasites and antimicrobial resistant bacteria. In this study, we 
investigated the carriage of extended-spectrum-cephalosporin-resistant (ESC-resistant) Escherichia 
coli, methicillin-resistant Staphylococcus aureus (MRSA) and species of hookworm and Giardia among 
camp dogs in remote Western Australian Aboriginal communities. A total of 141 canine faecal samples 
and 156 nasal swabs were collected from dogs in four communities of the Western Australian Kimberley 
region. Overall, ESC-resistant E. coli was detected in 16.7% of faecal samples and MRSA was isolated 
from 2.6% of nasal swabs. Of most significance was the presence of the community-associated Panton-
Valentine leucocidin (PVL)-positive MRSA ST93 and ST5 clones and ESC-resistant E. coli ST38 and 
ST131. The most prevalent zoonotic intestinal parasite infection was Ancylostoma caninum (66%). 
The prevalence of Giardia was 12.1%, with the main genotypes of Giardia detected being dog specific 
assemblages C and D, which are unlikely to cause disease in humans.
Greater than 60% of emerging human infectious diseases are zoonotic1. Companion animals, such as dogs, have 
been shown to be sources of zoonoses2, in part due to close, prolonged contact with humans and integration into 
environments of increased human population density. Parasitic and bacterial zoonoses are commonly found 
in household pets3. Recently, the prevalence of multidrug resistant Escherichia coli resistant to extended spec-
trum cephalosporins (ESCs), methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant 
Staphylococcus pseudintermedius (MRSP) in domestic pets has been increasing4–9.
Gram-negative bacteria resistant to critically important antimicrobials (CIAs) such as carbapenems and ESCs 
are of significant public health concern due to limited therapeutic options and the ability of such antimicrobial 
resistance to be transferred to sensitive Gram-negative bacteria via horizontal gene transfer10,11. It is possible that 
companion animals may serve as reservoirs for ESC-resistant E. coli due to the close associations between humans 
and pets12,13. Studies have reported human and companion animal isolates sharing the same genes and displaying 
identical clonal lineages14–17, suggesting transmission of the bacteria between household pets and humans.
MRSA is a zoonotic and zooanthroponotic agent identified among companion animals and a global health 
issue. The first human community-acquired MRSA (CA-MRSA) infections were reported in Australian 
Aboriginal and native Canadian communities in the 1990s18,19, and studies have also reported evidence of MRSA 
transmission between human and companion animals20–22.
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In addition to the growing threat from CIA resistant bacteria, the public health threat from zoonotic para-
sites requires close monitoring, particularly among isolated communities of low socioeconomic standing and 
with poor health education. Ancylostoma caninum is a zoonotic canine hookworm species and is one of the 
soil-transmitted helminths23. The most common route of hookworm infection is via penetration of the skin by 
hookworm larva24. As such, communities where the parasite is endemic, coupled with behavior of walking bare-
foot, increases the risk of infection. Zoonotic infection with Ancylostoma caninum can result in cutaneous larva 
migrans, a creeping, itchy rash caused by migrating larvae under the skin25.
Giardia is a cause of gastrointestinal infection which is common in humans around the world, particularly 
in developing regions26, and a high prevalence of Giardia infection among indigenous communities in Western 
Australia has been documented27,28. Clinical manifestations include diarrhea, nausea, and abdominal pain and 
distension25, and serious sequelae in infants and children include failure-to-thrive syndrome29.
Previous studies into zoonotic intestinal parasites from dogs in remote Aboriginal communities in the 
Kimberley region of Western Australia were conducted over 20 years ago27,30, and data on antimicrobial resistant 
(AMR) bacteria in companion animals in these communities is lacking. This study provides a contemporary 
examination of the zoonotic parasites and antimicrobial resistant bacteria from camp-dogs in Aboriginal com-
munities in the Kimberley region.
Results
Carriage of ESC-resistant E. coli. ESC-resistant E. coli was isolated from 12.8% (18/141) of faecal samples, 
with the majority coming from the West Kimberly communities (12 of 21 isolates). The 18 positive faecal samples 
yielded, in total, 21 ESC-resistant E. coli isolates.
The Isolates were defined by multi-locus sequence-type (MLST) with most isolates belonging to sequence type 
(ST) 38 (42.8%, n = 9). The remaining isolates were characterised as ST2144 (9.5%, n = 2), ST131 (9.5%, n = 2), 
ST1408 (4.3%, n = 1), ST3520 (4.3%, n = 1), ST1569 (4.3%, n = 1), ST68 (4.3%, n = 1), ST3268 (4.8%, n = 1), 
ST106 (4.8%, n = 1) and ST872 (4.8%, n = 1). The two ST131 isolates were identified in the East Kimberley 2 
(EK2) region while the ST2144 isolates were from West Kimberley 1 (WK1) region. As a result of low sequence 
coverage, the STs for two isolates could not be determined.
All ESC-resistant E. coli isolates were resistant to two or more classes of antimicrobials (multidrug resistant) 
with universal resistance to ceftriaxone and ampicillin. Two of the isolates from EK2, (ST38 and ST131), and one 
ST3268 isolate from East Kimberley 3 (EK3) demonstrated resistance or intermediate resistance to ciprofloxacin. 
The ST38 and ST131 isolates were also resistant to trimethoprim/sulfamethoxazole. Two ST38 isolates, from 
different locations, were resistant to six or more antimicrobial classes and carried corresponding resistance genes. 
The two phenotypically and genotypically distinguishable ST2144 were isolated from the same animal with addi-
tional resistance to cefoxitin and amoxicillin-clavulanate (Table 1).
All sequenced isolates were found to carry beta lactam resistance genes: blaCTX-M27 (n = 10), blaCTX-M14 (n = 5), 
blaCMY-2 (n = 3), blaTEM-1B (n = 6), blaCTX-M15 (n = 3), and blaTEM-33 (n = 1). Several other antibiotic class resistance 
genes were also carried by the isolates; including trimethoprim (drfA17), sulphamethoxazole (sul1/sul2), mac-
rolide (mph), erythromycin (erm), quinolone (qnrS1), chloramphenicol (cat A1) and tetracycline (tetA/tetD). 
Thirteen isolates harbored the macrolide resistance gene mph(A). Aminoglycoside resistance genes detected were 
aadA5 (n = 13), strA/strB (n = 4), and aac(3)-IId (n = 4). A tetracycline resistance gene (tetA or tetD) was detected 
in five isolates. Quinolone resistance (qnrS1) and chloramphenicol resistance (catA1) genes were also found in 
three isolates each. The erythromycin resistance gene (ermB) was harbored by one isolate.
Carriage of MRSA. MRSA was isolated from 2.6% (4/156) of the nasal swabs, two isolates from EK1, one 
isolate from EK2 and one isolate from WK1. The four MRSA isolates were cefoxitin and penicillin resistant, but 
trimethoprim/sulfamethoxazole, tetracycline, erythromycin, ciprofloxacin and gentamicin susceptible (Table 2). 
Two of the four MRSA isolates were identified as ST93. The remaining two isolates were identified as ST5 and 
ST872 (Table 2). All isolates carried beta-lactam (blaZ), methicillin (mecA) and efflux pump (norA) genes. The 
Panton Valentine leucocidin (PVL) associated genes, lukF-PV and lukS-PV, were detected in 3 of 4 isolates (ST93 
and ST5).
Carriage of zoonotic parasites. Based on molecular detection results of the species of interest, 82 dogs 
were infected with hookworm (A. caninum) alone, six dogs were infected with Giardia alone, and 11 dogs were 
infected with hookworm and Giardia combined. A total of 111 dogs were found to be infected with one or more 
parasites based on combined molecular and microscopic examination. Overall, hookworm infection was the 
most common with 93 of 141 dogs (66%) positive. The other helminths observed in the samples were Toxocara 
canis (4.3%, n = 6), Spirometra erinaceid (3.5%, n = 5), Taenia spp. (1.4%, n = 2), and Spirocerca lupi (0.7%, n = 1). 
Giardia was the second most prevalent protozoa in dogs (12.1%, n = 17) after Isospora spp. (12.7%, n = 18) fol-
lowed by Sarcocystis spp. (9.9%, n = 14). The prevalence of Giardia and hookworm in each community in the 
Kimberley region is shown in Table 3. EK1 had the highest crude prevalence of hookworm (93.8%) and Giardia 
(18.8%).
Most dogs from which sequencing was successful (12/17 dogs, 70.6%%) were carrying Giardia Assemblage 
C (GenBank accession numbers: MF974555-MF974558; MF974560, MF990014- MF990016, MF769400). Three 
Isolates; B1 HC10 (GenBank accession number: MF990017), K2–27 (100% similar to GenBank accession num-
ber: KY979492) and B1 HC34 (GenBank accession number: MF990018) were identified as assemblage D at the 
gdh locus. Evidence suggesting mixed populations was found in two isolates, B1 HC23 and B1 HC7. Isolate B1 
HC23 was identified as assemblage D at the gdh locus and assemblage C (GenBank accession number: MF974560) 
at the tpi locus. The sequence of Isolate B1 HC7 at the gdh locus matched representative GenBank accessions for 
www.nature.com/scientificreports/
3SCIEntIFIC REpORTS |  (2018) 8:8725  | DOI:10.1038/s41598-018-26920-5
assemblage C using the forward primer for Sanger sequencing and assemblage D when using the reverse primer. 
At the tpi locus the sequence was identified as assemblage A (GenBank accession number: MF974560) (Table 4).
Discussion
The current study provides information on the carriage of ESC-resistant E. coli, MRSA and zoonotic enteric para-
sites among camp dogs that are in close contact with Western Australian Aboriginal communities. ESC-resistant 
E. coli were carried by 16.7% of dogs with some of the isolates belonging to the globally disseminated ST131 and 
ST38 ESC-resistant pandemic clones. Additionally, camp dogs were colonized by PVL-positive CA-MRSA (ST93 
and ST5) clones at a low prevalence (2.6%); and zoonotic intestinal parasites Giardia and Ancylostoma caninum 
were present at prevalences of 12.1% and 66% respectively. It should be noted that the prevalences reported are 
crude, given the opportunistic nature of sampling, and that the numbers of dogs present in each region are only 
estimates, with no valid enumeration data available.
ST38 was identified as the major E. coli ST in the faecal samples collected in two community locations. ST2144 
and ST131 were also identified for more than one isolate. The two ST2144 were isolated from the same animal in 
the West Kimberly community. This sample grew 3 morphologically distinguishable colony types, however whole 
genome sequencing showed that only two separate genotypes were present. ST131 carrying blaCTX-M genes, which 
was isolated from two animals located in the East Kimberley community, can exist as a globally disseminated 
multi-drug resistant pandemic extra intestinal pathogenic E. coli responsible for causing variety of extra intestinal 
infections in humans, including urinary tract infection and bacteraemia31,32. Significantly, ST131 and ST38 have 
previously been reported as causes of disease in various animals, including dogs33–36. The limitations of this study 
do not allow conclusions to be drawn on how the sampled animals acquired these infections. It could be hypothe-
sized that they naturally circulate in dogs in these communities or alternatively they are spillover from the human 
population. However, these findings are of public health concern, given the possibility that these clonal types may 
be transferred from dogs to humans, and a larger scale study inclusive of human sampling may aid in determining 
the ecology of resistant E. coli in these populations.
PVL-positive ST93 -IV and PVL-negative ST5 -IV are community acquired (CA)-MRSA that have also been 
found in animals37,38. ST93-IV is the dominant CA-MRSA clone across Australia in humans, and has been associ-
ated with a range of skin and soft tissue infections, as well as severe invasive infections such as necrotizing pneumo-
nia38–40. The three MRSA isolates harbored the beta-lactamase gene (blaZ), the penicillin-binding protein, PBP 2a 
gene (mecA) and the efflux pump gene (norA). This finding is of important public health significance in these pop-
ulations, as these isolates are resistant to beta-lactam antibiotics which may be used for treatment of pneumonia, 
Isolate Origin MLST Resistance Genes Phenotypic resistance
B1 HC6 EK 2 ST131 aadA5, mph(A), sul1, dfrA17 blaCTX-M-15, gyrA (S83L, D87N, E678D), gyrB (D185E), parC (S80I, E475D) CRO, SXT, AMP, CIP
B1 HC22 EK 2 ST131 aadA5, mph(A), sul1, dfrA17 blaCTX-M-27, blaTEM-1B, aac(3)-IId strB, strA, sul2, tet(A), gyrA (S83L, E678D), gyrB (D185E) TET, CRO, CN, SXT, AMP, S
B1 HC19 EK 2 ST38 aadA5, mph(A), sul1, dfrA17, blaCTX-M-14, blaTEM-1B, aac(3)-IId, strB, strA, sul2, tet(D), catA1, gyrA (S83L, S828A), gyrB (D185E), parC (S80I), parE (I136V) TET, CRO, CN, SXT, C, AMP, S
B1 HC10 EK 2 ST1408 mph(A), blaCTX-M-14, tet(A) TET, CRO, AMP
B2 B2 WK 1 ST3520 aadA5, mph(A), sul1, dfrA17, blaCTX-M-27 CRO, SXT, AMP
B2 B4.A WK 1 ST2144 blaCMY-2 CRO, AMP, FOX, AMC
B2 B4.B WK 1 ST2144 blaTEM-33, blaCMY-2 CRO, AMP, FOX,, AMC
B2 B10.A WK 1 ST38 aadA5, mph(A), sul1, dfrA17, blaCTX-M-14, blaTEM-1B, aac(3)-IId, strB, strA, sul2, tet(D), catA1, gyrA (S83L, S828A), gyrB (D185E), parC (S80I), parE (I136V) TET, CRO, CN, SXT, C, AMP, S, AMC*
B2 B10.B WK 1 ST38 aadA5, mph(A), sul1, dfrA17, blaCTX-M-27, gyrA (S828A), gyrB (D185E), parE (I136V) CRO, SXT, AMP
B2 B12.A WK 1 ST38 aadA5, mph(A), sul1, dfrA17, blaCTX-M-27, gyrA (S828A), gyrB (D185E), parE (I136V) CRO, SXT, AMP
B2 B13 WK 1 ST38 aadA5, mph(A), sul1, dfrA17, blaCTX-M-27, gyrA (S828A), gyrB (D185E), parE (I136V) CRO, SXT, AMP
B2 B14 WK 1 ST38 aadA5, mph(A), sul1, dfrA17, blaCTX-M-27, gyrA (S828A), gyrB (D185E), parE (I136V) CRO, SXT, AMP
B2 B17.A WK 1 ST38 aadA5, mph(A), sul1, dfrA17, blaCTX-M-27, gyrA (S828A), parE (I136V) CRO, SXT, AMP
B2 B17.B WK 1 ST1569 dfrA17, blaCTX-M-27, gyrA (S828A), gyrB (D185E), parE (I136V) CRO, SXT, AMP
B2 B18 WK 1 ST-38 aadA5, mph(A), sul1, dfrA17, blaCTX-M-27 CRO, SXT, AMP
B2 B22 WK1 ST68 QnrS1, blaCTX-M-15 CRO, AMP
K2–10 EK3 ST3268 QnrS1, dfrA14, blaTEM-1B, blaCTX-M-15, gyrA (S828A) TET, CRO, AMP, CIP*
K1–22 EK2 ST38 aadA5, sul2, dfrA17, blaCTX-M-14, blaTEM-1B, aac(3)-IId, strB, strA, tet(D), catA1, gyrA (S83L), gyrB (D185E), parC (S80I), parE (I136V) AMP, SXT, TET, C, AMC*, S, CN, CIP*, CRO
K1–38 EK2 Unknown sul1, dfrA17, blaCTX-M-27 AMP, SXT, CRO
K1–39 EK2 ST106 aadA5, mph(A), dfrA17, blaCTX-M-14, cmlA1, erm(B) AMP, SXT, S, CRO
K1–41 EK2 Unknown sul2, QnrS1, blaCTX-M-11, blaTEM-1B AMP, CRO
Table 1. Genotypic and phenotypic antimicrobial resistance profile of ESC-resistant E. coli isolates collected from 
dog faeces in remote Australian communities. EK (East Kimberley), WK (West Kimberley), *(Intermediate), SXT 
(Trimethoprim/Sulfamethoxazole), TET (Tetracycline), FOX (Cefoxitin), CRO (Ceftriaxone), CN (Gentamicin), 
C (Chloramphenicol), AMP (Ampicillin), S (Streptomycin), CIP (Ciprofloxacin), AMC (Amoxicillin-clavulanate).
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skin and ear infections that are highly prevalent among Aboriginal communities41,42. As for E coli, a more detailed 
study to examine the ecology of these MRSA clones in Aboriginal communities and camp dogs is warranted.
The prevalence of Ancylostoma caninum in dogs identified in the current study is similar to a previous report 
from the same area, completed in 199327. The high prevalence of A. caninum increases the opportunity for spread 
of the infection to humans in the communities, which can cause cutaneous larva migrans43. Although A. caninum 
is a zoonotic agent, it is considered of minor public health significance as this species of hookworm rarely pro-
gresses past cutaneous infections23. Dog Health Programs in Aboriginal communities that were first introduced 
in the Kimberley region of Western Australia in 199244, used the anthelmintic Ivermectin to reduce the preva-
lence of scabies and hookworm in dogs. Unfortunately, the treatment was only able to reduce the intensity of the 
infection but did not significantly diminish the prevalence of canine hookworm44. The failure of eradication of 






B1 B19 EK 1 ST5 blaZ, mecA, norA FOX, P
aur, splB, splA, scn, sak, lukF-PV, lukS-
PV, hlb, hlgB, hlgA, hlgC, lukD, lukE, 
edinA, seg, sen, seu, sei, sem, seo
B1 B21 EK 1 ST93 blaZ, mecA, norA FOX, P splA, aur, splE, scn, sak, lukS-PV, lukE, hlb, hlgA, hlgC, hlgB, lukF-PV, lukD
B2 B61 WK 1 ST93 blaZ, mecA, norA FOX, P splA, splE, aur, scn, sak, hlb, lukF-PV, lukS-PV, lukE, lukD, hlgA, hlgC, hlgB
B1 HC17 EK 2 ST872 blaZ, mecA, norA FOX, P splB, splA, aur, splE, sak, scn, lukD, lukE, sea/sep, hlgA, hlgC, hlgB, seq, sek, hlb, seh
Table 2. Molecular characteristics and phenotypic antimicrobial resistance profiles of nasal MRSA isolates 
collected from dogs in remote Australian communities. EK 1 (East Kimberley, Community 1), EK 2 (East 
Kimberley, Community 2), WK 1 (West Kimberley, Community 1), FOX (cefoxitin), P (penicillin).
Origin
Ancylostoma 
caninum Prevalence (95% CI) Giardia spp. Prevalence (95% CI)
EK 1 15/16 93.8% (71.7, 98.9) 3/16 18.8% (6.6, 43.0)
EK 2 46/71 64.8% (53.2, 74.9) 9/71 8.5% (6.8, 22.4)
EK 3 12/26 46.2% (28.8, 64.5) 2/26 7.7% (2.1, 24.1)
WK 1 20/26 76.9% (57.9, 90.0) 3/26 11.5% (4.0, 29.0)
WK 2 0/2 0% (0.00, 65.8) 0/2 0% (0.00, 65.8)
Total 93/141 66%(57.8,73.3) 17/141 12.1% (7.7, 18.5)
Table 3. Prevalence of Giardia and hookworm in canine faeces collected in the Kimberley region.
Isolate
Gdh tpi Combined result
Assemblage Assemblage Assemblage
B1 B12 C C C
B2 B12 C C C
B2 B18 C NS C
B2 B25 NS C C
B1 B5 C C C
B1 B7 C C C
B1 HC10 D NS D
B1 HC23 D C D + C
B1 HC34 D NS D
B1 HC7 C + D A C + D + A
K1–2 C NS C
K1–5 C NS C
K1–31 C C C
K1–34 C C C
K1–41 C C C
K2–13 C C C
K2–27 D NS D
Table 4. Giardia assemblages identified in dog faeces based on combined sequencing data from gdh and tpi 
genes. NS: No sequence determined.
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received 3-monthly moxidectin treatments. As such these results are of concern, and may indicate anthelmintic 
resistance or heavy environmental contamination by dogs which have missed regular treatments.
The prevalence of Giardia infection in dogs in this study (12.1%, 95% CI 7.7, 18.5) was similar to findings in the 
same region over 20 years ago (17%)27 and to a national study of gastrointestinal parasites of dogs in Australia (9.3%, 
95% CI 7.8–10.8)45. This study found that the genotype of Giardia from dogs in the region were mostly canine-specific 
Assemblages C and D. The zoonotic Giardia Assemblage A was only found in one sample, and it would appear that 
the likelihood of transmission of Giardia between dogs and humans in the Kimberley Region remains low.
The management of dogs is of paramount importance in minimizing the spread of zoonotic agents through 
these communities. Dogs in this study were able to roam freely, and scavenged on human waste. Access to mate-
rials such as human faeces has the potential for dogs to become infected with human associated bacterial clones 
and parasites, and maintain them in the community. Ongoing de-sexing and treatment clinics together with 
continuous client education regarding good husbandry practices and correct anthelmintic, antiprotozoal and 
antibiotic administration are also important to prevent recurrent infections.
In conclusion, this study demonstrates the carriage of antimicrobial resistant bacteria and zoonotic enteric 
parasites amongst camp dogs in remote Western Australian communities. The carriage of human associated 
MRSA (ST93 and ST5) and ESC-resistant E. coli (ST131 and 38) identified in this study is of particular impor-
tance, and requires further study to determine whether there is movement of CIA resistant bacteria from humans 
to animals and the potential for zoonotic transmission to humans.
Methods
Study area. The Kimberley Region is in the north of Western Australia. The region is a remote area populated 
by Aboriginal communities. The samples were collected from three communities in the East Kimberley and two 
communities in the West Kimberley. Available information about total dog population and number of samples in 
each community are presented in Table 5.
Source of isolates. Work undertaken in this survey was approved by the Murdoch University Animal Ethics 
Committee (Permit #408 and #R2876/16), with all experiments performed in accordance with relevant guidelines 
and regulations. Nasal swabs were collected from 156 dogs from five communities. Of these dogs, faecal samples 
could be collected from 141, with the remaining having empty rectums. Sampling was conducted for diagnostic 
purposes by the Murdoch University veterinary team undertaking a neutering operation and dog health program 
in the Kimberley region in three-time periods; June 2016, October 2016 and June 2017. Sample numbers were 
based solely on dogs entering the neutering programme. Only dogs which had not been previously neutered were 
sampled to prevent resampling the same individual. Faecal samples were collected into standard 70 ml plastic 
containers. Nasal swab samples were collected using swabs into charcoal media (Copan, Italy). Samples were 
stored at 4 °C until processed.
Bacterial Isolation and detection. For MRSA isolation, swabs were plated onto Brilliance MRSA Agar 
(ThermoFisher Scientific) and incubated overnight at 37 °C. Colonies resembling MRSA were subcultured onto 
5% Sheep Blood Agar (Edwards Media). Screening for ESC-resistance was performed by incubating the fae-
cal samples onto Brilliance ESBL Agar (ThermoFisher Scientific) and incubating overnight at 37 °C. Colonies 
resembling ESBL E. coli were sub-cultured onto 5% Sheep Blood Agar (Edwards Media). If more than one colony 
morphology was identified on a plate an isolate from each colony type was taken. Identification of all isolates was 
conducted using a Bruker microflex MALDI-TOF.
Antimicrobial susceptibility testing. Isolates underwent susceptibility testing via disc diffusion according 
to the Clinical Laboratory Standards Institute (CLSI) Performance Standards for antimicrobial disk susceptibility 
tests M02-A1246. MRSA were tested using the following seven antimicrobials: trimethoprim/sulfamethoxazole, 
tetracycline, cefoxitin, erythromycin, penicillin, ciprofloxacin and gentamicin. E. coli isolates were tested using 
the following 12 antimicrobials: Trimethoprim/Sulfamethoxazole, tetracycline, cefoxitin, ceftriaxone, gentamicin, 
chloramphenicol, ampicillin, streptomycin, imipenem, ciprofloxacin, amoxicillin-clavulanate and meropenem. 
Zone diameter results were categorized as susceptible, intermediate and resistant using the clinical interpretative 
criteria specified in CLSI performance standard VET01-S347. If interpretive criteria was not present in VET01-S3, 
CLSI performance standard M100-S25 was used48.
Detection of resistance genes. DNA was extracted from isolates using a MagMax DNA multi sam-
ple kit (ThermoFisher Scientific) as per manufacturer’s instructions with the modification to omit the RNAse 
treatment step. Library preparation was performed using an Illumina NexTera XT library preparation kit as per 
Origin
Approximate population 
size of dogs Dogs sampled
East Kimberley (EK) 1 30 16
East Kimberley (EK) 2 unknown 71
East Kimberley (EK) 3 unknown 26
West Kimberley (WK) 1 100 26
West Kimberley (WK) 2 60 2
Table 5. Canine faecal samples by community and population.
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manufacturer’s instructions. Sequencing was performed on an Illumina MiSeq platform using a V3 2 × 300 kit. 
Reads were de novo assembled using CLC Genomics Workbench v9.5.4, and contig files uploaded to the Centre 
for Genomic Epidemiology (http://www.genomicepidemiology.org/) for screening for MLST, serotype, antimi-
crobial resistance genes, plasmid replicon type and virulence factors. SNPs within the quinolone-resistance deter-
mining regions of ST38 and ST131 isolates were identified using the Snippy programme within the Nullarbor 
bioinformatics pipeline49.
Parasite egg identification and DNA extraction. One gram of each faecal sample was examined for 
the presence of parasite eggs using flotation in saturated zinc sulphate, followed by examination under a light 
microscope. Briefly, approximately 1 g of faeces was mixed with 9 mL of zinc sulphate solution (specific gravity 
1.18) in a 10 mL centrifuge tube. The tube was centrifuged at 900 xg for five minutes with no brake. Additional 
zinc sulphate solution was added to form a positive meniscus and a cover slip was placed on the top of the tube. 
After approximately 5 minutes the cover slip was placed onto a slide and examined for the presence of parasites at 
100× and 400× magnification. DNA was extracted directly from all faecal samples using a Bioline Isolate II Faecal 
DNA Kit (Bioline), as per the manufacturer’s instructions. DNA extracts were stored at −20 °C until required.
Polymerase chain reaction. DNA extracts were subject to qPCR for identification of Giardia, conventional 
PCR for differentiating Ancylostoma species and conventional PCR for genotyping Giardia. An approximately 
380 bp section of internal transcribed spacer-2 (ITS-2) region of Ancylostoma spp. was amplified using a protocol 
modified from Smout et al.50. Primers used in this assay are listed in Table 6. The PCR reaction mix was prepared in 
a volume of 25 µL consisting of 12.5 µL GoTaq® Green Master Mix (Promega,USA), 0.25 µM of each primer, 6.25 µL 
nuclease-free water and 5 µL of template genomic DNA. The thermocycling conditions consisted of a pre-heating 
step at 94 °C for 2 min, followed by 40 cycles of 94 °C for 30 s, 64 °C for 30 s, 72 °C for 30 s, and a final extension of 
72 °C for 7 min. PCR products were viewed on a 1.5% agarose gel dyed with SYBR®Safe DNA gel stain.
The presence of Giardia in all samples were screened at the glutamate dehydrogenase (gdh) locus using a 
quantitative PCR (qPCR) procedure previously described by Yang et al.51. Conventional PCR amplification of 
the glutamate dehydrogenase (gdh) and the triose phosphate isomerase (tpi) locus was conducted on all sam-
ples found positive for Giardia on qPCR. An approximately 733 bp portion of the gdh gene was obtained using 
formerly published primers52,53. For this nested PCR, primers GDHeF and GDH 2 were used in the primary 
reaction, and primers GDHiF and GDH 4 were used in the secondary reaction (Table 2). PCR reaction volume 
for each sample in both primary and secondary PCRs was 20 µL, containing 10 µL GoTaq® Green Master Mix 
(Promega,USA), 0.25 µM of each primer, 4 µL nuclease-free water and 5 µL of template genomic DNA. Cycling 
conditions for primary PCR were 1 cycle of 94 °C for 2 min, followed by 35 cycles of 94 °C for 30 s, 55 °C for 30 s 
and 72 °C for 60 s with a final extension of 72 °C for 7 min and a 12 °C hold. The cycling conditions for the sec-
ondary PCR were similar to the primary PCR, except the annealing temperature, which was 52 °C. PCR of the tpi 
locus utilised a nested PCR protocol developed by Sulaiman et al. (2003) with slight modifications54. Primary and 
secondary primers are shown in Table 6. The predicted PCR product sizes of primary and secondary reactions 
were 605 bp and 530 bp, respectively. The PCR reaction for the primary reaction comprised of: 10 µL GoTaq® 
Green Master Mix (Promega,USA), 0.25 µM of each primer, 4 µL nuclease-free water and 5 µL of template DNA. 
The secondary reaction contained: 12.5 µL GoTaq® Green Master Mix (Promega,USA), 0.25 µM of each primer, 
6.25 µL nuclease-free water and 5 µL of DNA. The following cycling conditions were used for both primary and 
secondary PCRs: 1 cycle of 94 °C for 2 min, followed by 35 cycles of 94 °C for 45 s, 60 °C for 45 s and 72 °C for 1 min 


























Table 6. PCR primers for Ancylostoma spp. and Giardia.
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with a final extension of 72 °C for 7 min. The amplified DNA products from the gdh and tpi PCR were visualized 
on a 1.5% agarose gel containing SYBR®Safe DNA gel stain.
PCR products of the Ancylostoma spp., Giardia gdh and Giardia tpi reactions were excised from gels and 
purified using the Wizard®SV Gel and PCR Clean-Up System kit (Promega, USA) before DNA sequencing. DNA 
sequencing was performed at the Australian Genome Research Facility (Perth, WA).
Following screening by qPCR for Giardia, only samples which were positive upon Sanger sequencing on the 
gdh and/or tpi assays were considered as confirmed positives. Ancylostoma positive status was also based on 
Sanger sequence positive PCR results.
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
Accession codes. B1 B12 gdh (accession number: MF 990015), B1 B12 tpi (accession number: MF 974557), 
B2 B18 gdh (accession number: MF 990016), B2 B25 tpi (accession number: MF 974558), B1 B5 gdh (accession 
number: MF 769400),B1 B5 tpi (accession number: MF 974555), B1 B7 gdh (accession number: MF 990014), 
B1 B7 tpi (accession number: MF 974556), B1 HC10 gdh (accession number: MF 990017), B1 HC23 tpi (acces-
sion number: MF 974560), B1 HC34 gdh (accession number: MF 990018), B1 HC7 tpi (accession number: MF 
974559).
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